Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Defect information notice issued for Ibuprofen tablets of Aspar

The Medicines and Health products Regulatory Agency (MHRA) has issued a class four medicines defect information notice for Ibuprofen 200mg and 400mg tablets of Aspar Pharmaceuticals.

The patient information leaflets (PILs) within the ibuprofen packs are missing some information which should be documented in section three and section four of the PIL, Aspar Pharmaceuticals Limited has said.


How to take the tablets (section three)

Current information in the PILCorrect information that should be included in the PIL
Seek medical attention IMMEDIATELY if you accidentally take too many tablets.Seek medical attention IMMEDIATELY if you accidentally take too many tablets. If you have taken more than you should, or if children have taken this medicine by accident always contact a doctor or nearest hospital to get an opinion of the risk and advice on action to be taken. The symptoms can include nausea, stomach pain, vomiting (may be blood-streaked), headache, ringing in the ears, confusion and shaky eye movement. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness and dizziness, blood in urine, cold body feeling, and breathing problems have been reported.

Possible side effects (section four)

Current information in the PILCorrect information that should be included in the PIL
(No appropriate wording related to DRESS syndrome)A severe skin reaction known as DRESS syndrome can occur. Symptoms of DRESS include: skin rash, fever, swelling of lymph nodes and an increase of eosinophils (a type of white blood cells).

Product Description

MDR number of the product is MDR 054-07/20 and ibuprofen is the active pharmaceutical ingredient.
ProductPack SizePL Number
Aspar Ibuprofen 200mg Caplets (GSL)16PL 08977/0015
ProductPack SizePL Number
Nisa Ibuprofen Tablets BP 200mg (GSL)16PL 08977/0016
Lloyds Pharmacy Ibuprofen 200mg Tablets (GSL)16PL 08977/0016
Lloyds Pharmacy Ibuprofen200mg Tablets (P)24, 48, 16PL 08977/0016
Lifestyle Ibuprofen Tablets BP 200mg (GSL)16PL 08977/0016
Ibucalm 200mg Tablets (GSL)16PL 08977/0016
Ibucalm 200mg Tablets (P)24, 48, 16PL 08977/0016
Careway Ibuprofen 200mg Tablets (GSL)16PL 08977/0016
Careway Ibuprofen 200mg Tablets (P)25, 48PL 08977/0016
Asda Ibuprofen 200mg Tablets (P)48PL 08977/0016
ProductPack Size(s)PL Number
Ibucalm 400mg Tablets (P)24, 48, 96PL 08977/0017
Asda Ibuprofen 400mg Tablets (P)48, 96PL 08977/0017
Careway Ibuprofen 400mg Tablets (P)24, 48PL 08977/0017
Lloyds Pharmacy Ibuprofen 400mg Tablets (P)12, 24, 48, 96PL 08977/0017

Advice for healthcare professionals

Community pharmacists have been adviced that if any of the above products are supplied or dispensed, then they should ensure that patients are aware of the missing information as mentioned above.

It is important that any patients who notice any symptoms following the use of the product should seek immediate medical advice.

The patients who experience side effects from taking any medicines should be encouraged to report a suspected problem or incident via the Yellow Card scheme and seek medical advice accordingly.

More For You

Students from retail sector using bursary aid for postgraduate education

The charity has given £28 million worth of financial aid to postgraduate students.

Bursary applications open for pharmacy students

A leading charity that provides financial aid for the families of those working in the pharmacy, convenience and grocery sector, has announced postgraduate bursary applications open for 2025/2026.

The Leverhulme Trade Charities Trust (LTCT) bursary scheme is open to students on postgraduate courses, whose parent, carer, spouse is employed in an eligible profession, such as convenience retailer, supermarket store worker, or pharmacy technician.

Keep ReadingShow less
The NHS has changed payment structure for consultations

The NHS has changed payment structure for consultations

Maximising new medicine services can be a game changer for pharmacists

Adele Curran, chief operations officer at RWA Pharmacy Ltd, looks at the changes to NMS and the financial opportunities they offer for Community Pharmacies

English pharmacies have been delivering new medicine services (NMS) since October 2011. They have successfully increased the effective use of medicines across their communities and also increased their revenue through the claiming structure.

Keep ReadingShow less
Camizestrant Cuts Breast Cancer Progression by 50% – New Hope

There was a 56 per cent reduction in the risk of disease progression or death

Pic credit: iStock

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death by half, a finding that could be practice changing, experts said on Sunday.

The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test called a liquid biopsy to indicate the need for a change in treatment in women with a common form of breast cancer, even before tumor growth can be detected on imaging.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

Acute sore throats had the most consultations

Pic credit: istock

Pharmacy First has already seen over five million patients

The Pharmacy First scheme has helped over five million patients with minor illnesses, according to NHS England.

Around 2.4 million people received help without booking an appointment at their local pharmacy for seven common conditions including sore throat, earache or shingles.

Keep ReadingShow less
122 pharmacists were successful in achieving credentials

122 pharmacists were successful in achieving credentials

Pic credit: Istock

RPS reports record increase in credentialing submissions

The Royal Pharmaceutical Society (RPS) has revealed that credentialing submissions rose by 190 per cent compared to last year, with 226 assessments completed and 122 pharmacists successfully credentialed.

The data also reveals increasing uptake in primary care settings and continued strong representation from hospital-based pharmacists.

Keep ReadingShow less